• 1. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 2. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 3. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 4. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 5. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383

• Solvents and Organic Chemicals Organic Compounds Alkaloids and derivatives Tropane alkaloids Tropane alkaloids
• Solvents and Organic Chemicals Organic Compounds Alkaloids and derivatives Tropane alkaloids

Recent Advances in the Application of 3,3-Difluoro-8-azabicyclo[3.2.1]octane (CAS: 1234616-11-5) in Medicinal Chemistry

The compound 3,3-difluoro-8-azabicyclo[3.2.1]octane (CAS: 1234616-11-5) has recently garnered significant attention in the field of medicinal chemistry due to its unique structural properties and potential therapeutic applications. This bicyclic scaffold, characterized by its fluorine substitutions and nitrogen heteroatom, offers a versatile platform for the development of novel bioactive molecules. Recent studies have explored its utility in drug design, particularly in targeting central nervous system (CNS) disorders and infectious diseases.

One of the key advantages of 3,3-difluoro-8-azabicyclo[3.2.1]octane is its ability to enhance the pharmacokinetic properties of drug candidates. The fluorine atoms contribute to improved metabolic stability and membrane permeability, while the rigid bicyclic structure provides conformational restraint, which is often beneficial for receptor binding. Recent research has demonstrated its incorporation into lead compounds for the treatment of neurodegenerative diseases, such as Alzheimer's and Parkinson's, where blood-brain barrier penetration is a critical factor.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers synthesized a series of derivatives based on 3,3-difluoro-8-azabicyclo[3.2.1]octane and evaluated their efficacy as serotonin receptor modulators. The results indicated that these compounds exhibited high selectivity and potency, with one derivative showing promise as a potential antidepressant. The study highlighted the scaffold's ability to fine-tune receptor interactions through strategic functionalization.

Another notable application of this scaffold is in the development of antiviral agents. A recent preprint on bioRxiv detailed the use of 3,3-difluoro-8-azabicyclo[3.2.1]octane as a core structure in inhibitors targeting viral proteases. The researchers reported that the fluorine atoms played a crucial role in stabilizing the inhibitor-enzyme complex, leading to enhanced antiviral activity against SARS-CoV-2 and other RNA viruses. This finding underscores the scaffold's potential in addressing emerging infectious diseases.

Despite these promising developments, challenges remain in the large-scale synthesis and optimization of 3,3-difluoro-8-azabicyclo[3.2.1]octane-based compounds. Recent advances in flow chemistry and catalytic fluorination have begun to address these issues, enabling more efficient and sustainable production routes. A 2024 review in Organic Process Research & Development summarized these technological breakthroughs, emphasizing their impact on the scalability of fluorinated bicyclic compounds.

In conclusion, 3,3-difluoro-8-azabicyclo[3.2.1]octane (CAS: 1234616-11-5) represents a highly promising scaffold in medicinal chemistry, with applications spanning CNS therapeutics, antiviral agents, and beyond. Ongoing research continues to uncover its full potential, driven by innovations in synthetic methodologies and a deeper understanding of its structure-activity relationships. As the field progresses, this scaffold is likely to play an increasingly important role in the discovery of next-generation pharmaceuticals.

• 1783656-28-9(5,5-difluoro-2-azabicyclo[2.2.1]heptane;hydrochloride)
• 478866-39-6(exo-3-fluoro-8-azabicyclo[3.2.1]octane)
• 1254104-06-7(3,3-Difluoro-8-azabicyclo[3.2.1]octane hydrochloride)
• 1951425-16-3((S)-4,4-Difluoro-2-(fluoromethyl)pyrrolidine hydrochloride)
• 1909320-20-2(3,3-difluoro-9-azabicyclo3.3.1nonane hydrochloride)
• 1378571-68-6(4,4-Difluoro-2-methylpiperidine hydrochloride)
• 1234616-37-5(4,4-Difluoro-2-methylpiperidine Hydrochloride)
• 478866-38-5(exo-3-fluoro-8-azabicyclo[3.2.1]octane;hydrochloride)
• 1638768-09-8(4-fluoro-2-methyl-piperidine;hydrochloride)
• 1404286-36-7(3-fluoro-8-azabicyclo[3.2.1]octane)